Le Lézard
Classified in: Health
Subjects: OFR, PVP

Select Medical Corporation Closes Private Placement of $675 Million of 6.250% Senior Notes due 2026

MECHANICSBURG, Pa., Dec. 10, 2019 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation ("Select") has completed its private placement of $675 million aggregate principal amount of its 6.250% Senior Notes due 2026 as additional notes (the "Additional Notes") under same indenture as Select's existing $550 million aggregate principal amount of 6.250% senior notes due 2026 that were originally issued on August 1, 2019 and, as such, will form a single series and trade interchangeably with such previously issued notes.

Selects intends to use a portion of the net proceeds of this offering, together with a portion of the net proceeds from a $615 million incremental term loan and, if required, available cash, to loan to its joint venture subsidiary, Concentra, Inc. ("Concentra"), pursuant to the terms of an intercompany loan agreement, an amount which will be used by Concentra to repay in full all currently outstanding term loan indebtedness under Concentra's first lien credit agreement. Any remaining net proceeds from the offering will be used by Select for general corporate purposes.

The notes and related guarantees were sold in a private placement, solely to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), or outside the United States to persons other than "U.S. persons" in compliance with Regulation S under the Securities Act. The notes and related guarantees have not been registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.

This notice does not constitute an offer to sell the notes, nor a solicitation for an offer to purchase the notes, in any jurisdiction in which such offer or solicitation would be unlawful. Any offer of the notes will be made only by means of a private offering memorandum. This press release is being issued pursuant to and in accordance with Rule 135c under the Securities Act.

Investor inquiries:
Joel T. Veit
Senior Vice President and Treasurer

SOURCE Select Medical Holdings Corporation

These press releases may also interest you

at 23:22
Hawkeye Systems, Inc. is pleased to announce the creation of a strong body cam platform for biosurveillance and real-time monitoring of issues such as the Coronavirus "It's the personnel at the front line that are likely to be exposed first so our...

at 22:00
Capsule Technologies, a leading global provider of medical device integration, clinical surveillance, and patient monitoring for hospitals and healthcare organizations, announced today it opened a new office in Dubai's Jebel Ali Free Zone expanding...

at 22:00
In an effort to focus on continuous patient safety and quality improvements, as well as address dynamic changes in today's global health care environment, Joint Commission International (JCI) announces the publication of The Joint Commission...

at 21:55
A December 16 article on Healthline tackles the question of whether it is better to brush or floss first when practicing dental hygiene. The article states that, by flossing first, individuals are dislodging particles stuck between teeth that are...

at 21:45
Blue Health Intelligence (BHI) published an article confirming Airrosti's methods improve care efficiency, reduce total cost of care, and limit the utilization of high-cost imaging and surgeries for musculoskeletal (MSK) injuries. Airrosti, a large...

at 21:19
The coronavirus outbreak is having a potentially significant social and economic impact in China. WuXi Biologics is closely monitoring the coronavirus outbreak and is complying with guidance from the relevant authorities. Our management team is...

News published on 10 december 2019 at 16:15 and distributed by: